Seegene Unveils Advanced mpox Detection Assays for Research Use

Seegene Expands mpox Research Use Only Product Offerings

Seegene Inc., a leading provider of innovative PCR molecular diagnostics, is making strides in the detection of mpox with its newly introduced Novaplex™ MPXV/OPXV plus Assay. This research-use-only (RUO) product is tailored to identify Clade I, a variant known for higher transmission and mortality rates compared to Clade II.

Advanced Detection Capabilities

The Novaplex™ MPXV/OPXV plus Assay is crafted to detect three targets responsible for mpox disease. It effectively identifies non-variola Orthopoxvirus (OPXV) and mpox virus (MPVX), providing specific confirmation of MPXV Clade I. This enhanced ability positions the assay as a critical tool for healthcare professionals investigating the spread of mpox.

Alignment with WHO Standards

Notably, the assay adheres to the target product profiles issued by the World Health Organization (WHO). These profiles set a benchmark that ensures manufacturers and researchers are on the right track when developing assays for virus detection, particularly regarding mpox.

Aiming to Mitigate Global Health Threats

Seegene is responding promptly to the global public health emergency regarding the mpox outbreak, developing two key assays aimed at detecting mpox variants. The company's commitment is evident as it plans to supply these products to nations in need, bolstering international efforts against the spread of the virus.

Multiple Virus Detection

One of the remarkable features of the new offerings is their capability to detect multiple viruses. In addition to the Novaplex™ MPXV/OPXV Assay (RUO), the Novaplex™ HSV-1&2/VZV/MPXV Assay (RUO) is designed to identify four viruses simultaneously, including herpes simplex virus types 1 and 2, varicella-zoster virus, and mpox virus. This multi-target approach enhances the assay's utility in clinical and research settings.

Commitment to Fighting mpox

As stated by Daniel Shin, Executive Vice-President and Chief Global Sales and Marketing Officer at Seegene, the company is fully aware of the increasing research demands due to the ongoing mpox spread. This new RUO assay aims to support efforts in affected countries and contribute to the global fight against mpox.

Background on Seegene

With a robust history of over 23 years in research and development, Seegene has become a cornerstone in multiplex PCR technology. The company's expertise was particularly showcased during the COVID-19 pandemic when it facilitated the distribution of over 340 million COVID-19 tests to more than 100 countries globally. The hallmark of Seegene's technology lies in its ability to simultaneously test for several pathogens in a single assay, yielding valuable insights into infection profiles.

In light of the recent data gathered from January 2024 to September 6, 2024, there have been reports of 24,851 suspected cases, 5,549 confirmed cases, and 643 deaths attributed to mpox across African Union member states, as per the Africa Centres for Disease Control and Prevention (Africa CDC). Moreover, as the mpox variant spreads, affected regions now include countries beyond Africa.

Frequently Asked Questions

What is the new Novaplex™ MPXV/OPXV plus Assay?

The Novaplex™ MPXV/OPXV plus Assay is a research-use-only product specifically designed to detect Clade I mpox and identify non-variola Orthopoxvirus.

How does the assay contribute to mpox research?

By accurately detecting mpox variants, the assay assists healthcare professionals and researchers in understanding the virus’s behavior and controlling its spread.

What is the importance of WHO's target product profiles?

The WHO's target product profiles serve as guidelines for manufacturers when developing assays, ensuring they meet important standards for effective virus detection.

How effective is Seegene's technology in simultaneous testing?

Seegene's multiplex PCR technology allows the detection of multiple pathogens in one go, providing critical information on illness progression and infection types.

What was Seegene's role during the COVID-19 pandemic?

During the pandemic, Seegene was instrumental in supplying rapid and effective COVID-19 testing solutions globally, which showcased its capabilities in the diagnostics field.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.